Posted by Michael Wonder on 10 Nov 2021
Moderna's COVID-19 vaccine (Spikevax) - provisional determination granted for proposed use in children and booster shot for adults under evaluation
10 November 2021 - The TGA has granted a provisional determination to Moderna in relation to its COVID-19 vaccine, Spikevax.
Currently, Spikevax is provisionally approved for use in individuals 12 years of age or older. The granting of this determination means that Moderna is eligible to apply to vary the provisional approval for the vaccine for use in younger children.
